Skip to content
DraconiticResearch
Search Sources API
189,273 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BY-NC 4.0The European Journal of Public Health

Mapping existing hospital-based cancer prevention pathways in Europe: insights from EUnetCCC

Abstract

Background: Cancer remains a leading cause of morbidity and mortality in Europe, yet prevention is still poorly integrated into health and care systems. Hospitals and Comprehensive Cancer Centres (CCCs) have strong potential to deliver and coordinate prevention activities, but structured hospital-based pathways remain limited. Within the Joint Action EUnetCCC, we aim to map hospital-based cancer prevention pathways in Europe, describing their models and level of integration within healthcare systems.

Methods: We conducted a scoping review following PRISMA-ScR guidelines. The study was structured according to a PCC framework, including hospitals and cancer centres, delivering primary and secondary cancer prevention pathways, examining their organizational models and policy frameworks, across European Economic Area countries, UK, and Switzerland. We searched PubMed, Scopus, Google Scholar, existing networks and organizations’ websites, with no time limits.

Results: Preliminary findings show limited availability of structured hospital-based cancer prevention pathways. 88% of interventions focus on secondary prevention, 33% on primary prevention, with some studies reporting both. Breast and lung cancer are the main targets (22% each). Pathways address smoking (44%) through cessation programs, genetic/familial predisposition (33%) through counselling, infections (22%) through vaccination. Strengths include awareness campaigns, multidisciplinary collaboration, and improved access to early detection; challenges include low participation, workforce shortages, access inequalities, and limited hospital–community integration.

Conclusions: Hospital-based cancer prevention pathways are emerging across Europe but remain unevenly implemented, due to regional/national models where prevention occurs outside hospitals and reimbursement systems prioritize care. Strengthening structured pathways and prevention hubs could improve equity and enhance the impact of cancer prevention.

Key messages: • In Europe there are limited examples of hospitals that embed cancer prevention in routine care pathways.

• Mapping barriers and facilitators of hospital prevention pathways can inform implementation of cancer prevention models in cancer centers.

Related

  1. Multifaceted Regulation of Tea Astringency: A Review of Intervention Pathways by Co-Existing Flavor Components
    Shikun Liu, Tianhui Huang, Yifei Zhang +5
    MoleculesPeer-reviewedCC BY 4.0General medicineCrossref
  2. Prediction of in-hospital mortality at a 72-hour intensive care landmark in patients with sepsis and pre-existing hypertension: development and external validation
    Y. Chen, Y. Cai, H. Bian +1
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  3. Effectiveness of community-based care pathways and relapse prevention strategies in schizophrenia: a systematic review and bibliometric analysis
    Isymiarni Syarif, Hasnawati Amqam, Noyumala +2
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Psychiatry & mental healthCrossref
  4. Parental attitudes toward myopia prevention: insights from an Australian survey
    Bingjie Wang, Kathleen Watt, Zhi Chen +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  5. Knowledge, attitudes and behaviours related to tick awareness and prevention among users of urban green spaces: insights from stakeholder focus groups
    J. L. Taylor-Egbeyemi, S. Masterton, C. Robin
    medRxivPreprintAll rights reservedFull textEpidemiology & public healthmedRxiv
BibTeX
@article{perrone2026mapping,
  title = {{Mapping existing hospital-based cancer prevention pathways in Europe: insights from EUnetCCC}},
  author = {D Perrone and A Sabatelli and E Giacobini and A Malenkovic and A C Cadoré and V Margiotta and A Moyne and D Nicoara and B Fervers and S Boccia},
  journal = {The European Journal of Public Health},
  year = {2026},
  month = oct,
  doi = {10.1093/eurpub/ckag169.1119},
  url = {https://doi.org/10.1093/eurpub/ckag169.1119},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Mapping existing hospital-based cancer prevention pathways in Europe: insights from EUnetCCC
AU  - D Perrone
AU  - A Sabatelli
AU  - E Giacobini
AU  - A Malenkovic
AU  - A C Cadoré
AU  - V Margiotta
AU  - A Moyne
AU  - D Nicoara
AU  - B Fervers
AU  - S Boccia
PY  - 2026
DA  - 2026/10/01
JO  - The European Journal of Public Health
DO  - 10.1093/eurpub/ckag169.1119
UR  - https://doi.org/10.1093/eurpub/ckag169.1119
AB  - Background: Cancer remains a leading cause of morbidity and mortality in Europe, yet prevention is still poorly integrated into health and care systems. Hospitals and Comprehensive Cancer Centres (CCCs) have strong potential to deliver and coordinate prevention activities, but structured hospital-based pathways remain limited. Within the Joint Action EUnetCCC, we aim to map hospital-based cancer prevention pathways in Europe, describing their models and level of integration within healthcare systems.  Methods: We conducted a scoping review following PRISMA-ScR guidelines. The study was structured according to a PCC framework, including hospitals and cancer centres, delivering primary and secondary cancer prevention pathways, examining their organizational models and policy frameworks, across European Economic Area countries, UK, and Switzerland. We searched PubMed, Scopus, Google Scholar, existing networks and organizations’ websites, with no time limits.  Results: Preliminary findings show limited availability of structured hospital-based cancer prevention pathways. 88% of interventions focus on secondary prevention, 33% on primary prevention, with some studies reporting both. Breast and lung cancer are the main targets (22% each). Pathways address smoking (44%) through cessation programs, genetic/familial predisposition (33%) through counselling, infections (22%) through vaccination. Strengths include awareness campaigns, multidisciplinary collaboration, and improved access to early detection; challenges include low participation, workforce shortages, access inequalities, and limited hospital–community integration.  Conclusions: Hospital-based cancer prevention pathways are emerging across Europe but remain unevenly implemented, due to regional/national models where prevention occurs outside hospitals and reimbursement systems prioritize care. Strengthening structured pathways and prevention hubs could improve equity and enhance the impact of cancer prevention.  Key messages: • In Europe there are limited examples of hospitals that embed cancer prevention in routine care pathways.  • Mapping barriers and facilitators of hospital prevention pathways can inform implementation of cancer prevention models in cancer centers.
SN  - 1101-1262
SN  - 1464-360X
ER  -